005500 — Samjin Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Market Cap
KR₩226bn
Enterprise Value
KR₩331bn
Revenue
KR₩292bn

Annual balance sheet for Samjin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37,286	24,489	11,711	4,663	4,006
Net Total Accounts Receivable
Net Total Receivables	53,334	51,429	57,684	59,883	61,455
Total Inventory
Prepaid Expenses
Total Current Assets	150,110	146,860	139,872	134,268	146,180
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75,260	102,526	168,901	198,068	191,640
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	244,151	269,033	332,496	406,557	419,901
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,707	33,935	49,514	81,652	144,550
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	46,677	55,577	98,328	131,213	154,536
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	197,474	213,456	234,168	275,344	265,365
Total Liabilities & Shareholders' Equity	244,151	269,033	332,496	406,557	419,901
Total Common Shares Outstanding